By using this site, you agree to the IDC Privacy Policy

Jul 18, 2019 - Real-time IDC Research® opinion on industry news, trends and events

China Introduces Medical Reform in Drug Procurement and Distribution, Bringing Opportunities and Challenges to Multinational Pharmaceutical Companies

By: Lianfeng WuVice President, Chief Research Analyst, Leon XiaoSenior Research Manager, Vertical Industry Research and Consulting, IDC China

You need a subscription to access this IDC link. Log in to see if you have access.

For more information please contact us or call one of our worldwide offices.

Coverage